Standardization of 13-color high-sensitivity measurable residual disease (MRD) assessment in B-cell lymphoblastic leukemia (B-ALL) treated with novel anti-CD19 immunotherapies
- Resource Type
- article
- Source
- Pediatric Hematology Oncology Journal, Vol 7, Iss 4, Pp S14- (2022)
- Subject
Pediatrics RJ1-570 - Language
- English
- ISSN
- 2468-1245